Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® Plus

NCT07251608 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer
Fatigue

Interventions

DRUG: Niagen®Plus

Sponsor

ChromaDex, Inc.